Versant Venture Capital VI, L.P. - 22 Jun 2021 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: 10%+ Owner
Signature: By: /s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director
Issuer symbol: IPSC
Transactions as of: 22 Jun 2021
Net transactions value: +$2,000,000
Form type: 4
Filing time: 23 Jun 2021, 16:30:28 UTC
Previous filing: 17 Jun 2021
Next filing: 23 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IPSC	Common Stock	Conversion of derivative security		+9,936,011	+333%		12,916,814	22 Jun 2021	Direct	F1, F2
transaction	IPSC	Common Stock	Conversion of derivative security		+614,095			614,095	22 Jun 2021	See footnote	F3, F4
transaction	IPSC	Common Stock	Purchase	$2,000,000	+100,000	+16%	$20.00^*	714,095	22 Jun 2021	See footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IPSC	Series A Preferred Stock	Conversion of derivative security	$0	-25,000,000	-100%	$0.000000^*	0	22 Jun 2021	Common Stock	9,936,011		Direct	F1, F2
transaction	IPSC	Series C Preferred Stock	Conversion of derivative security	$0	-1,545,125	-100%	$0.000000^*	0	22 Jun 2021	Common Stock	614,095		See footnote	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
F2	The reportable securities are owned directly by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.
F3	Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
F4	The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.